Navigation Links
ClearStar Launches COVID-19 Testing Service For Employers
Date:5/21/2020

ClearStar, a provider of Human Capital IntegritySM technology-based services specializing in background and medical screening, announces the launch of a testing service aimed at supporting employers with their COVID-19 return-to-work planning and keeping their workforce safe. The new service is provided by ClearStar’s Medical Information Services (“MIS”) business through Clinical Reference Laboratory, Inc. (“CRL”), one of the largest privately held clinical testing laboratories in the U.S., and it includes both an antibody and a diagnostic test.

In the first instance, employees receive the CRL ClearTM kit, which is a dried blood spot finger prick test that is used to identify the presence, or lack, of COVID-19 antibodies in the blood, which are produced by the body in response to the virus. This includes IgA, IgM, and IgG antibodies, which are produced at different stages of the immune system response. A positive test result indicates that the employee has been previously infected by COVID-19 and has developed antibodies that might provide the employee with immunity. The CRL ClearTM kit is based on the Roche Elecsys® Anti-SARS-CoV-2 antibody test, which has received the CE mark and U.S. Food and Drug Administration Emergency Use Authorization.

Employees testing positive for the CRL ClearTM test, or those initially displaying symptoms, receive the CRL Rapid ResponseTM kit, which is a saliva-based molecular diagnostic test to determine if the virus is active. Those testing positive, meaning they are currently infected with COVID-19, will automatically be contacted by a licensed doctor to discuss the results and next steps. Any employee testing positive at either stage also receives instructions on self-isolation.    

The company’s customers are able to order the tests using the same process as for their existing ClearStar drug and clinical screening programs. Test collection kits are shipped either in bulk to the employer or direct to the employees (or job applicants), with the samples being self-collected by the employee and sent back to the CRL lab for testing. Employees also complete a questionnaire ahead of receiving the test collection kit and subsequently register the test collection kit online. The results of the tests are reported via the ClearStar platform within 24 hours, on average, of the samples being received by the lab and are provided in the same format, based on employer preference, as the customer receives their other drug or background screening reports from the company.

Robert Vale, CEO of ClearStar, said: “Balancing the equally important goals of getting people back to work and ensuring their safety and well-being is top priority for employers. We are proud to be able to offer our customers a new COVID-19 testing service, and by partnering with Clinical Reference Laboratory, whose tests are easy to self-administer, we can offer a reliable and quick turnaround. This new service—alongside our existing suite of background and medical screening solutions—will help employers to make more informed hiring and return-to-work decisions to get people into work quicker while maintaining public safety.”

To place an order, companies may contact the ClearStar Medical Information Services office at 321.821.3383 or info@medicalreviewoffice.com.

About ClearStar

ClearStar, Inc. is a leading provider of Human Capital IntegritySM technology-based services specializing in background and medical screening. It provides employment intelligence direct to employers and via channel partners/consumer reporting agencies (“CRAs”) to support better recruitment and other decisions affecting employees by increasing the quality, reliability, and visibility of information.

A seven-time Inc. 5000 honoree and founding member of the National Association of Professional Background Screeners, ClearStar has provided innovative technology solutions to businesses in the human capital management industry from its corporate offices in Alpharetta, Georgia since 1995. For more information about ClearStar, please visit: http://www.clearstar.net.

Read the full story at https://www.prweb.com/releases/clearstar_launches_covid_19_testing_service_for_employers/prweb17137646.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. DuPont Nutrition & Biosciences Launches Bonlacta™ Dairy Enzyme in North America for Lactose-Free Market
2. ILC Dover Reacts to Rising Demand for PPE During the COVID-19 Crisis, Rapidly Launches a New Healthcare Respirator Innovation
3. DuPont Launches YO-MIX® PRIME to Help Yogurt Manufacturers Create Their Dream Yogurt
4. Ixlayer Launches COVID-19 Clinical Testing Platform to Power Labs, and Health Systems for in Clinic and Remote Testing
5. Shoreline Biome Launches Convenient Lysis-Free DNA Amplicon Product
6. USARAD Including its SecondOpinions.com Division, Launches a Screening Program to Provide Medical Expertise During the Current COVID-19 Pandemic
7. G5 Launches New Cross-Channel Spend Optimizer That Improves Digital Advertising Performance Up To 25%
8. Veran launches new navigated triple needle brush and new navigated catheter to help physicians diagnose and guide treatment of early stage lung cancer
9. Lifecycle Biotechnologies launches second generation CHEM+POUR Bag
10. RoosterBio Launches the Only Umbilical Cord hMSC System in the World Designed for Cell Therapy Product Development
11. BioInformatics Launches New Experts-on-Demand Qualitative Research Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2020)... PHOENIX (PRWEB) , ... July 03, 2020 , ... ... is proud to earn outstanding recognition and multiple awards for not only the ... the ABM portfolio, SoME® Skincare and Vivace® Microneedle RF. All the brands built ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... software solutions for biopharmaceutical R&D, today announced that it has entered into ... full-length multispecific antibodies (Multiclonics®), to support their translational and clinical research strategy ...
(Date:6/23/2020)... ... 2020 , ... The field of quantitation of large molecules or proteins has ... area. However, the use of mass spectrometry in this field has gained a lot ... do you choose which approach to use (LBA or MS)?” In many cases, ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... The SDX® ... in 16 countries, has reached its 20th anniversary of worldwide use. Introduced in ... at top universities including University of Pennsylvania, University of Michigan, University of Maryland, ...
(Date:7/18/2020)... MILWAUKEE (PRWEB) , ... July 16, 2020 , ... “We ... at Third Wave Bioactives. “It’s the only technology of its kind on the market ... flavor of onions with the protective capacity of traditional cultured ingredients, creating a natural ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Technology (MIT) has expanded the company’s exclusive license to include clinical applications ... point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast ...
(Date:7/7/2020)... ... 2020 , ... Bio-IT World has announced the winners of ... University of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia Alliance were ... outstanding examples of how technology innovations and strategic initiatives can be powerful forces ...
Breaking Biology Technology: